U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. Reports, Manuals, & Forms
  4. Reports
  5. Economic Impact Analyses of FDA Regulations
  6. Regulations Regarding "Intended Uses" (Final Rule) Regulatory Impact Analysis
  1. Economic Impact Analyses of FDA Regulations

Regulations Regarding "Intended Uses" (Final Rule) Regulatory Impact Analysis

The final rule clarifies but does not change FDA’s interpretation and application of existing intended use regulations for medical products. The benefits of this rule are additional clarity and certainty for manufacturers and stakeholders regarding evidence that is relevant in evaluating whether an article is intended for use as a drug or device. This final rule is not expected to impose any significant additional costs on firms.

Regulatory Impact Analysis

Regulations Regarding "Intended Uses" (Final Rule) (PDF- 140KB)

Docket: FDA- 2015-N-2002

Federal Register: 86 FR 41383, August 2, 2021

Back to Top